| Demographic and clinical characteristics mean ± SD (range) |
| Age (years) |
39,9 ±11,7 (21-64) |
| Gender |
N (%) |
| Female |
11 (42,3) |
| Male |
15 (57,7) |
| Type of epilepsy |
N (%) |
| Neocortical temporal lobe Epilepsy |
1 (3,8) |
| Mesial temporal lobe epilepsy |
19 (73,1) |
| Frontal lobe epilepsy |
3 (11,5) |
| Parietal lobe epilepsy |
2 (7,7) |
| Occipital lobe epilepsy |
1 (3,8) |
| AEDs employed (mg per day) |
mean ± SD (range) |
| Valproate |
1129 ± 694,5 (600-2000) |
| Carbamazepine |
1069 ± 277,4 (600-1600) |
| Clonazepam |
2 ± 0,9 (1-4) |
| Clobazam |
48 ± 17,2 (20-80) |
| Phenitoin |
250 ±50,7 (200-300) |
| Lamotrigine |
361 ±111,2 (200-600) |
| Topiramate |
250 ± 70,7 (100-300) |
| Plasma level concentration before nimodipine (µg/ml) mean ± SD (range) |
| Carbamazepine |
10,55 ± 3,4 (4,26-12,3) |
|
